SEOUL, April 24 (Korea Bizwire) — South Korea said Saturday it has signed a deal with U.S. pharmaceutical giant Pfizer Inc. to import additional Pfizer vaccine doses for 20 million people in a move that could ease public concerns about a vaccine shortage. The deal came after South Korean health minister Kwon Deok-cheol held two [...]
SEOUL, Feb. 27 (Korea Bizwire) — A group of 300 medical workers treating novel coronavirus patients started receiving the first batch of the vaccine developed by U.S. pharmaceutical giant Pfizer Inc. in South Korea on Saturday, one day after the country kicked off a free vaccination campaign. Doctors, nurses and other health professionals treating COVID-19 [...]
SEOUL, Feb. 23 (Korea Bizwire) — A South Korean panel of experts said Tuesday that vaccines for the novel coronavirus by U.S. pharmaceutical company Pfizer Inc. showed a more than 95 percent efficacy rate, and the use of the vaccine is not problematic for young people. The advisory board consisting of outside experts announced its [...]
SEOUL, Feb. 21 (Korea Bizwire) — South Korea will begin administering 117,000 doses of Pfizer vaccines to medical staff on Saturday as the vaccines are expected to arrive in the country later this week, Prime Minister Chung Sye-kyun said Sunday. “On Feb. 26, 117,000 doses of Pfizer vaccines will arrive in the country and the [...]
SEOUL, July 20 (Korea Bizwire) — South Korean pharmaceutical companies will start selling generic versions of the smoking cessation drug Champix, following the expiration of its patent here, industry sources said Monday. The drug by U.S. pharmaceutical giant Pfizer, also referred to as varenicline tartrate, helps people to stop smoking by relieving cravings for nicotine [...]
BEVERLY HILLS, Calif., Apr. 10 (Korea Bizwire) — TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQX:TOMZ), a global company specializing in disinfection and decontamination essentials, announced today that SteraMist® implemented an iHP® Custom Build-In System to a newly constructed Pfizer facility in Chesterfield, MO. TOMI utilizes its premier Binary Ionization Technology® (BIT™) platform through the manufacturing, licensing, servicing, [...]
SEOUL, Mar. 27 (Korea Bizwire) – Concerns are growing after media outlets reported that the price of new drugs developed in the U.S. could spike as a result of a renegotiated free trade agreement. According to the Ministry of Trade, Industry and Energy, South Korea agreed to revise its pharmaceutical pricing and reimbursement policy to give [...]
SEOUL, Apr. 29 (Korea Bizwire) — The Supreme Court of Korea has ruled against Pfizer Ireland Pharmaceuticals, which sued six Korean pharmaceutical companies for violation of patent rights related to Sildenafil, a main ingredient in the production of impotency drugs. The court said on April 28 that the six companies, including CJ CheilJedang and Hanmi [...]
SEOUL, April 20 (Korea Bizwire) – As it is expected that Pfizer’s Xalkori cancer drug will be covered by the national health insurance in Korea, the 10 million won (US$9,225) burden that patients are currently facing will be dramatically reduced starting next month. According to a statement from the Ministry of Health and Welfare and the [...]
NEW YORK, July 16 (Korea Bizwire) — Life expectancy continues to climb — up to more than 81 years for women and 76 years for men – but many of us have concerns around aging. Pfizer is challenging Americans to address their #FOGO – Fear of Getting Old – as the next phase of Get [...]